Fujian Wanchen Biotechnology Group Co., Ltd. (SHE:300972)
China flag China · Delayed Price · Currency is CNY
165.38
+18.90 (12.90%)
Last updated: Apr 30, 2025

SHE:300972 Revenue

Fujian Wanchen Biotechnology Group had revenue of 10.82B CNY in the quarter ending March 31, 2025, with 124.02% growth. This brings the company's revenue in the last twelve months to 38.32B, up 186.77% year-over-year. In the year 2024, Fujian Wanchen Biotechnology Group had annual revenue of 32.33B with 247.86% growth.

Revenue (ttm)
38.32B
Revenue Growth
+186.77%
P/S Ratio
0.77
Revenue / Employee
4.85M
Employees
7,904
Market Cap
29.65B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202432.33B23.04B247.86%
Dec 31, 20239.29B8.74B1,592.03%
Jan 1, 2023549.26M114.56M26.35%
Jan 1, 2022434.70M-15.28M-3.40%
Dec 31, 2020449.98M-925.68K-0.21%
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Jan 1, 2018 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition